Is Kohl’s at Risk of Derailing Its Recovery?

FAN Editor

Kohl’s put in one of the strongest performances of any department store chain over the holidays, posting some of the best comparable-store sales numbers around. That’s an encouraging development for a chain that looked like it might follow Macy’s and J.C. Penney toward the abyss. Continue Reading Below Although those […]

Better Buy: Intrexon Corporation vs. Celgene

FAN Editor

Two very different companies are hoping to make their mark in cell therapy. Intrexon Corporation (NYSE: XON) formed its Precigen subsidiary last year to develop gene and cell therapies. Celgene (NASDAQ: CELG) recently announced its acquisition of Juno Therapeutics (NASDAQ: JUNO), a move that puts the big biotech front and […]